Company / Total Assets
Marker Therapeutics, Inc. Total Assets History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$68.1M
FY2021
5-year range
$46.4M / $68.1M
FY2018-FY2021
Trend
+47.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $62M to $68M over the past 3 years.
Based on SEC 10-K filings.
$68M in FY2021.
Improved from $62M to $68M over the past 3 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.1%, indicating consistent growth.
- In FY2021, total assets increased 47.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $68.1M | +47.0% |
| FY2019 | $46.4M | -25.4% |
| FY2018 | $62.1M | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026